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On February 4, 2010 the Illinois Supreme Court struck down Illinois' medical practice
reform bill, P.A. 94-677, when it decided Lebron v. Gottlieb Memorial Hospital.
Although the court only considered the unconstitutionality of the cap on non-economic
damages contained in that bill, an inseverability provision resulted in the invalidation of
all of its provisions. The end result of the Lebron decision extends much further than
the striking of the cap on non-economic damages. It affects such areas as medical
liability insurance law, physician discipline, public disclosure of information, the
admissibility of physician statements into evidence, and expert witness standards. The
Lebron holding has raised a significant obstacle to the implementation of a wide range
of legislative measures intended to improve both the delivery and quality of healthcare
services in Illinois. This article explains the impact of Lebron in these collateral, but
important, areas of the law.
The Stark Law in Retrospect ............ PATRICK A. SUrON 15
Considering the ultimate goals of preventing the over-utilization of medical services and
protecting the Medicare program, are the numerous phases of the Stark Law and their
concomitant regulations effective; or, conversely, has the legislation served to impede
entrepreneurialism among physicians to the detriment of innovations and better
integration in the delivery of medical treatment? This article endeavors to answer the
above question through an analysis of the policy goals behind the legislation; the
evolution of its regulations; its effect on competitiveness in the field of medicine; and the
ethical considerations implicated by the issue of physician self-referral. It further offers
some proposals which attempt to address the problem of physician self-referral abuse
while at the same time reducing the complexity and breadth of the Stark law and its
regulations. The article concludes by noting that to truly change the practice of
inappropriate self-referral as well as the culture of over-utilization, it is necessary not
only to target specific relationships and practices prone to abuse, but to realign the
financial incentives created by our current payment mechanisms as well.
The False Claims Act and the Eroding
Scienter in Healthcare Fraud Litigation .......... RICHARD DOAN 49
This article addresses the federal government's expansive methods in tackling
healthcare fraud, particularly in misapplying the False Claims Act. Although tasked
with the obligation to curtail the fraudulent submission of Medicare & Medicaid claims,
the U.S. government must rein in the current trend to utilize the False Claims Act
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against smaller medical providers. As the Act's original focus has ebbed in significance,
the government has increasingly applied the False Claims Act to circumstances that do
not evince actual fraud. In doing so, federal courts have effectively eroded the statute's
critical scienter requirement. The federal common-law doctrines of "payment by
mistake" and "unjust enrichment" adequately address the payment of non-fraudulent,
albeit false, Medicare & Medicaid claims. Yet the federal government pursues these
appropriate remedies only rarely and in the alternative, essentially when the government
fails under the False Claims Act. Thus, this article argues for reform, calling for a
clearer delineation between remedial and punitive measures. In cases involving smaller
medical providers, courts should strictly limit the False Claims Act to those instances
where fraud is clearly manifest.
Squeezing the Middleman: Ending Underhanded
Dealing in the Pharmacy Benefit Management
Industry Through Regulation ............... MARK MEADOR 77
Pharmacy benefit management (PBM) companies are the middlemen of the
pharmaceutical industry, designing plans for sponsors and insurers and pushing the
products of manufacturers. Their unique position can often create conflicts of interest,
which has been the basis of much litigation. This article reviews the structure of the
PBM industry and analyzes concerns arising from its handling of prescription drug
pricing, manufacturer rebates and discounts, and mail order pharmacies. After
surveying several legislative proposals, it concludes with a comprehensive outline for
legislation to eliminate underhanded dealing in the industry and lower the cost of
prescription drugs.
Is State Power to Protect Health Compatible
With Substantive Due Process Rights?... . . . . . . . ALLAN J. JACOBS 113
Public health laws may mandate drastic limitations on individual liberty, such as forced
medication and quarantine. This results in a tension between public health laws and
guarantees of liberty such as the Due Process Clauses of the Fifth and Fourteenth
Amendments to the United States Constitution. The Supreme Court has resolved this
tension in favor of one or the other of these legal principles, depending on the facts and
issues involved. Nevertheless, Supreme Court jurisprudence is internally consistent.
The Court has applied a level of scrutiny that, while rigorous, is more flexible than strict
scrutiny. I denote this as "enhanced public health scrutiny." Applying this scrutiny, the
Court will uphold public health legislation if it protects an inchoate class of people who
may not yet be identifiable, who will incur a specific disease or injury absent the law,
but who will not experience this disease or injury if the law is enforced. If this doctrine
were explicit, it would constitute a clear guideline to courts seeking to balance health
and liberty concerns. This guideline would be consistent with current case law, and
would not impact on law affecting reproductive liberty.
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